Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin shows signs of capitulation with weak demand and rising losses; market bottom not confirmed yet.

Market News
05 Jun 2026
AMBCrypto
View Source
Bearish
Bitcoin shows signs of capitulation with weak demand and rising losses; market bottom not confirmed yet.

Bitcoin's price has dropped about 16% this week, testing the $60k support level amid growing market fear. On-chain data reveals that demand for Bitcoin is contracting significantly, with both spot and futures markets showing reduced buying interest. More than half of Bitcoin's supply is now at an unrealized loss, and realized losses are rising, indicating that many holders are selling at a loss. This combination of weak demand, increasing losses, and ongoing selling pressure suggests that the market is still in a capitulation phase, and a confirmed bottom has not yet been reached, leaving Bitcoin vulnerable to further declines below $55k.

More News

AAVE token jumps over 10% in 24 hours, hitting $163 amid $140K short liquidations.

AAVE token jumps over 10% in 24 hours, hitting $163 amid $140K short liquidations.

The cryptocurrency AAVE surged 9.31% within four hours to reach $163, extending its 24-hour gain to 10.07%. This price increase was accompanied by $140,000 in short liquidations on major exchanges like Binance, Bybit, and OKX, while no long liquidati...

Market News
Bullish
4 hours ago
Bitcoin, Ethereum, Solana, and XRP spot ETFs see $65M inflows on Sept 28, signaling broad institutional interest.

Bitcoin, Ethereum, Solana, and XRP spot ETFs see $65M inflows on Sept 28, signaling broad institutional interest.

On September 28, all four major crypto spot ETFs—Bitcoin, Ethereum, Solana, and XRP—recorded net inflows totaling about $65 million, highlighting growing institutional demand beyond Bitcoin alone. Bitcoin ETFs led with $31.07 million, followed by Eth...

Market News
Bullish
4 hours ago
Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Poolbeg Pharma has secured funding to complete its clinical trials through to the second quarter of 2028. The company is currently recruiting patients for its TOPICAL trial of POLB 001, a drug aimed at preventing cytokine release syndrome in cancer p...

Market News
Bullish
4 hours ago
Genflow Biosciences to reveal dog longevity trial results and advance glaucoma and liver disease programs

Genflow Biosciences to reveal dog longevity trial results and advance glaucoma and liver disease programs

Genflow Biosciences will present full results from its canine ageing trial at the Animal Longevity Summit in Toronto, highlighting the safety and potential health benefits of its GF-1004 treatment aimed at slowing ageing. The company is also progress...

Market News
Bullish
4 hours ago
Bitcoin dips below $83K, wiping out $500M in leveraged crypto bets amid oil and gold market shocks

Bitcoin dips below $83K, wiping out $500M in leveraged crypto bets amid oil and gold market shocks

Bitcoin's price fell below $83,000 on September 28-29, triggering the liquidation of about $500 million in leveraged crypto positions and impacting 129,197 traders. The drop was influenced by rising oil prices after geopolitical tensions and a rare 3...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App